These findings suggested that CD8+ CTLs were positively correlated with most of the immune suppressive signatures, such as MDSC presence, T cell co-inhibition, antigen-presenting cell co-inhibition, and inflammation-promotion (Supplementary Figures 2F–J), suggesting that these factors may collectively protect tumor cells from attack by CTLs. The gene discussed is CD8A; the disease is neoplasm.